{"product_id":"american-academy-of-dermatology-annual-meeting-2026","title":"American Academy of Dermatology Annual Meeting 2026","description":"\u003ch1 class=\"product_title entry-title\"\u003eAmerican Academy of Dermatology Annual Meeting 2026\u003c\/h1\u003e\r\n\u003cstrong\u003e+ Target Audience: Dermatologists, Dermatologic Surgeons, Pediatric Dermatologists, Cosmetic Dermatologists, Dermatopathologists, and Cutaneous Oncologists\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003e+ Information:\u003c\/strong\u003e\r\n\u003cp data-path-to-node=\"2\"\u003eThe 2026 American Academy of Dermatology (AAD) Annual Meeting arrives at a pivotal moment for the field, showcasing late-breaking data poised to reshape treatment paradigms across dermatology’s most challenging conditions. The program features comprehensive sessions on phase 3 readouts, representing years of clinical development and potential first-in-class approvals. The event reflects a broader maturation of the dermatology pipeline, defined by oral precision therapies, novel biologic mechanisms, and an increased focus on treating historically underserved diseases. Key focus areas include innovations in atopic dermatitis, plaque psoriasis, hidradenitis suppurativa (HS), vitiligo, cutaneous oncology, and the evolving role of AI and teledermatology in modern practice.\u003c\/p\u003e\r\n\r\n\u003ch3 data-path-to-node=\"3\"\u003eLearning Objectives\u003c\/h3\u003e\r\n\u003cp data-path-to-node=\"4\"\u003eFollowing participation in this activity, the learner should be able to:\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"5\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,0,0\"\u003eReview and apply basic knowledge and skills in medical dermatology, dermatologic surgery, pediatric dermatology, and dermatopathology.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,1,0\"\u003eUpdate their knowledge about recent advances in the diagnosis, management, and treatment of diseases of the skin, hair, nails, and mucous membranes.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,2,0\"\u003eAss\u003cspan class=\"citation-2844 citation-2845 citation-2846 citation-end-2846\"\u003eess the relationship of evidence-based diagnostic approaches and therapies with new dermatologic treatment developments.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,3,0\"\u003e\u003cspan class=\"citation-2841 citation-2842 citation-2843 citation-end-2843\"\u003eSelf-assess current practice management skills and develop strategies for improving these skills.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,4,0\"\u003e\u003cspan class=\"citation-2838 citation-2839 citation-2840 citation-end-2840\"\u003eApply new procedural skills into eve\u003c\/span\u003e\u003cspan class=\"citation-2838 citation-2839 citation-end-2839\"\u003eryday practice.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3 data-path-to-node=\"6\"\u003e\u003cspan class=\"citation-2836 citation-2837 citation-end-2837\"\u003eTarget Audience\u003c\/span\u003e\u003c\/h3\u003e\r\n\u003cul\u003e\r\n \t\u003cli data-path-to-node=\"7\"\u003e\u003cspan class=\"citation-2834 citation-2835\"\u003eDermatologists and others involved in the delivery of dermatologic care.\u003c\/span\u003e\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"7\"\u003e\u003cb data-path-to-node=\"7\" data-index-in-node=\"73\"\u003e\u003cspan class=\"citation-2834 citation-2835 citation-end-2835\"\u003eBest for Dermatologists, Dermatologic Surgeons, Pediatric Dermatologists, Cosmeti\u003c\/span\u003e\u003cspan class=\"citation-2834 citation-end-2834\"\u003ec Dermatologists, Dermatopathologists, and Cutaneous Oncologist\u003c\/span\u003es.\u003c\/b\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3 data-path-to-node=\"8\"\u003eTopics\u003c\/h3\u003e\r\n\u003cp data-path-to-node=\"9\"\u003eThe comprehensive scientific agenda spans multiple core specialties within dermatology. Detailed topics covered during the meeting include:\u003c\/p\u003e\r\n\u003cp data-path-to-node=\"10\"\u003e\u003cb data-path-to-node=\"10\" data-index-in-node=\"0\"\u003eMedical Dermatology \u0026amp; Pipeline Therapeutics\u003c\/b\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"11\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"11,0,0\"\u003e\u003cb data-path-to-node=\"11,0,0\" data-index-in-node=\"0\"\u003eNext-Generation Oral Therapies:\u003c\/b\u003e Evaluating high-performance oral agents closing the efficacy gap with biologics, including Icotrokinra (an oral IL-23 receptor antagonist) for plaque psoriasis without mandatory TB testing requirements.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"11,1,0\"\u003e\u003cb data-path-to-node=\"11,1,0\" data-index-in-node=\"0\"\u003eNovel Biologics in Atopic Dermatitis:\u003c\/b\u003e 24-week efficacy and safety results from the COAST 1 and COAST 2 Phase 3 trials investigating Amlitelimab (a non-depleting anti-OX40 ligand antibody) as monotherapy and alongside topical treatments.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"11,2,0\"\u003e\u003cb data-path-to-node=\"11,2,0\" data-index-in-node=\"0\"\u003eAdvancements in Non-Segmental Vitiligo:\u003c\/b\u003e Efficacy and safety profiles of Upadacitinib in adolescents and adults based on the Viti-Up Phase 3 studies.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"11,3,0\"\u003e\u003cb data-path-to-node=\"11,3,0\" data-index-in-node=\"0\"\u003eHidradenitis Suppurativa (HS) Breakthroughs:\u003c\/b\u003e Assessment of durable 54-week efficacy data for the oral JAK1 inhibitor Povorcitinib, highlighting its favorable safety profile and mechanistically targeted reduction of heterogeneous cytokine architecture in HS.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-path-to-node=\"12\"\u003e\u003cb data-path-to-node=\"12\" data-index-in-node=\"0\"\u003eDermatologic Surgery \u0026amp; Cutaneous Oncology\u003c\/b\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"13\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"13,0,0\"\u003e\u003cb data-path-to-node=\"13,0,0\" data-index-in-node=\"0\"\u003eMelanoma Care Disparities:\u003c\/b\u003e Analyzing survival outcomes and racial\/gender disparities across the melanoma care continuum, including evidence showing lower rates of home or hospice end-of-life care among minority patients.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"13,1,0\"\u003e\u003cb data-path-to-node=\"13,1,0\" data-index-in-node=\"0\"\u003eSurgical Technique Updates:\u003c\/b\u003e Procedural integration and guidelines for managing challenging cutaneous malignancies and complex dermatologic anomalies.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-path-to-node=\"14\"\u003e\u003cb data-path-to-node=\"14\" data-index-in-node=\"0\"\u003eInflammatory \u0026amp; Autoimmune Diseases\u003c\/b\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"15\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"15,0,0\"\u003e\u003cb data-path-to-node=\"15,0,0\" data-index-in-node=\"0\"\u003eSystemic Inflammation \u0026amp; Cardiovascular Risk:\u003c\/b\u003e Transcriptomic evidence linking psoriasis and atopic dermatitis to shared atherosclerotic risk pathways.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"15,1,0\"\u003e\u003cb data-path-to-node=\"15,1,0\" data-index-in-node=\"0\"\u003eThe “Diaper to Diaper” Hypothesis:\u003c\/b\u003e Tracing systemic inflammation from growth stunting in pediatric atopic dermatitis to cardiovascular disease manifestations in adult patients.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"15,2,0\"\u003e\u003cb data-path-to-node=\"15,2,0\" data-index-in-node=\"0\"\u003eTYK2 Inhibitors \u0026amp; Safety Profiles:\u003c\/b\u003e Phase 2b and Phase 3 efficacy of allosteric TYK2 inhibitors (e.g., envudeucitinib, zasocitinib) that preserve clinical efficacy while minimizing JAK-associated safety concerns.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-path-to-node=\"16\"\u003e\u003cb data-path-to-node=\"16\" data-index-in-node=\"0\"\u003ePediatric Dermatology\u003c\/b\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"17\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"17,0,0\"\u003e\u003cb data-path-to-node=\"17,0,0\" data-index-in-node=\"0\"\u003eBiologic Interventions in Adolescents:\u003c\/b\u003e Assessing robust Phase 3 responses (PASI 90 and PASI 100) to targeted treatments in adolescent cohorts weighing ≥40 kg.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"17,1,0\"\u003e\u003cb data-path-to-node=\"17,1,0\" data-index-in-node=\"0\"\u003eAdolescent vs. Adult Pathophysiology:\u003c\/b\u003e Investigating understudied pathophysiologic distinctions, such as those observed in teenage versus adult female acne.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-path-to-node=\"18\"\u003e\u003cb data-path-to-node=\"18\" data-index-in-node=\"0\"\u003eAesthetic \u0026amp; Cosmetic Dermatology\u003c\/b\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"19\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"19,0,0\"\u003e\u003cb data-path-to-node=\"19,0,0\" data-index-in-node=\"0\"\u003eCosmetic Injections:\u003c\/b\u003e Practical approaches to product selection, relevant anatomy review, injection methods for botulinum toxin and dermal fillers, and strategies to minimize adverse events.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"19,1,0\"\u003e\u003cb data-path-to-node=\"19,1,0\" data-index-in-node=\"0\"\u003eScalp \u0026amp; Hair Expertise:\u003c\/b\u003e Understanding physiological and structural specificities (e.g., straight vs. curly hair biology) to optimize outcomes for hair loss, dandruff, and cosmetic compliance.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"19,2,0\"\u003e\u003cb data-path-to-node=\"19,2,0\" data-index-in-node=\"0\"\u003eCompliance-Driven Galenics:\u003c\/b\u003e Bridging the gap between clinical potency and sensory\/cosmetic appeal to improve treatment adherence across diverse patient profiles.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-path-to-node=\"20\"\u003e\u003cb data-path-to-node=\"20\" data-index-in-node=\"0\"\u003eTechnology, Practice Management \u0026amp; Diversity\u003c\/b\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"21\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"21,0,0\"\u003e\u003cb data-path-to-node=\"21,0,0\" data-index-in-node=\"0\"\u003eDigital Dermatologic Innovation:\u003c\/b\u003e Evaluating the pros, cons, and clinical integration of Artificial Intelligence (AI) and Teledermatology to manage workload and expand patient access.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"21,1,0\"\u003e\u003cb data-path-to-node=\"21,1,0\" data-index-in-node=\"0\"\u003eClinical Trial Diversity:\u003c\/b\u003e Strategies for improving remote dermatology care, ensuring accurate diagnosis in skin of color, and boosting diverse representation in late-stage clinical research.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"21,2,0\"\u003e\u003cb data-path-to-node=\"21,2,0\" data-index-in-node=\"0\"\u003eAntibiotic Stewardship:\u003c\/b\u003e Reframing antibiotics in acne management as anti-inflammatory rather than antimicrobial agents, focusing on narrow-spectrum agents (like sarecycline) to preserve gut microbiome integrity.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e","brand":"Meducourse","offers":[{"title":"Default Title","offer_id":43163711963234,"sku":"MED-AMB09703","price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/American-Academy-of-Dermatology-Annual-Meeting-2026.jpg?v=1785419542","url":"https:\/\/meducourse.com\/products\/american-academy-of-dermatology-annual-meeting-2026","provider":"Meducourse","version":"1.0","type":"link"}